Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ABSI
ABSCI CORPORATION
NASDAQ
$8.71
▼ DOWN 7.54% (-0.71)

KEY STATISTICS

Market Cap$1.48 B
52w High$12.05
52w Low$2.24
Dividend Yield—
Frequency—
P/E-10.89
Volume2.50M
Shares Out.169.40M

COMPANY

LEADERSHIP

Sean McClain
CHIEF EXECUTIVE
Sean McClain

COMPENSATION 2026

Salary$689,936
Stock Awards$650,484
Incentive Plan Pay$372,565
All Other Comp.$14,000
Total$3,686,615

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 22, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
140

PRICE TARGET

Target High$16.00
Target Low$9.00
Target Median$12.00
Target Consensus$12.40

UPCOMING EARNINGS

DateNov 16, 2026
DayMonday
Rev. Est.$697.57K
NOV
16
MON

PRICE

$8.71 ▼ DOWN 7.54% (−$0.71)
$8.60$8.80$9.00$9.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM8.71

About Absci Corporation

https://www.absci.com ↗

Absci Corporation, founded in 2011 and based in Vancouver, Washington, offers biologic drug candidates and production cell lines through an integrated platform that unifies drug discovery and cell line development for partners in the U.S.

INDUSTRY

Biotechnology

A SERVICE ABSCI CORPORATION IS KNOWN FOR

Integrated Drug Creation™ Platform

Absci's platform uses generative AI and scalable wet lab tech to rapidly design and develop biologics, enabling partnerships with pharma to create novel protein therapeutics efficiently.

COMPETITORS

COMPETITOR
ABCL COMPARE
RLAY COMPARE
RXRX COMPARE
SDGR COMPARE

Revenue by Products

IconPRODUCTQ2-2021
Technology Development Revenue$592K
Collaborative Revenue$136K

ETFS HOLDING THIS STOCK

ETFS HOLDING
105
LISTED HERE
18
RANKED BY POSITION SIZE
ARKG
4.83% · 10.9M
XBI
0.44% · 5.5M
VTI
0.00% · 4.5M
IWM
0.04% · 3.5M
SCHA
0.03% · 653.1K
PTH
1.10% · 328.7K
LABU
0.30% · 200.4K
DFAS
0.01% · 140.9K
XRSU.L
0.04% · 126.2K
RSSL
0.04% · 66.0K
WDNA.L
1.19% · 43.4K
HLTH
3.49% · 30.8K
SYZ
0.13% · 9.2K
URTY
0.02% · 5.6K
VETS
0.07% · 3.7K
AVSC
0.00% · 3.0K
AESG
0.25% · 524
RESM
0.04% · 261

INSTITUTIONAL OWNERSHIP

SHARES OWNED
64.97%
HOLDERS
246
TOP 12 OF 246 · RANKED BY POSITION SIZE
Fmr LLC
25.4M sh · $294.5M
Ark Investment Management LLC
13.7M sh · $41.18M
Blackrock, Inc.
12.2M sh · $141.11M
Redmile Group, LLC
8.3M sh · $28.8M
State Street Corp
8.1M sh · $93.85M
Vanguard Group Inc
7.9M sh · $27.61M
Ameriprise Financial Inc
7.0M sh · $81.03M
Advanced Micro Devices Inc
5.7M sh · $66.23M
Adage Capital Partners Gp, L.L.C.
5.7M sh · $66.12M
Two Sigma Investments, LP
5.5M sh · $63.67M
Blackrock Inc.
5.3M sh · $16.46M
D. E. Shaw & Co., Inc.
5.2M sh · $60.73M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
OFFICER
Somaratne Ransi Mudalinayake
— · —
2026-03-03
★
OFFICER: CMO, HEAD OF R&D
Somaratne Ransi Mudalinayake
Purchase · 650.0K shares
2026-03-03
★
OFFICER: CMO, HEAD OF R&D
Somaratne Ransi Mudalinayake
Purchase · 383.0K shares
2026-08-03
★
DIRECTOR
Szela Mary T
Purchase · 12.9K shares
2026-06-30

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 5
5 GRADES IN THE LAST 12 MONTHS
BTIG BUY Needham BUY Truist Securities BUY HC Wainwright & Co. BUY Guggenheim BUY

SECTORS PEERS

PEERPRICE
ERAS$18.03COMPARE
MGTX$13.82COMPARE
MLTX$14.99COMPARE
CRVS$14.16COMPARE
OLMA$10.27COMPARE
VSTM$7.22COMPARE
RGNX$9.66COMPARE
PRTA$9.33COMPARE